Navigation Links
Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America
Date:11/11/2009

DALLAS, Nov. 11 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its North American commercial launch of MuGard, an FDA approved treatment for oral mucositis, a debilitating side effect of radiation treatment and chemotherapy. Access intends to commercially launch MuGard in North America in the first quarter of 2010. Key strategic items pertaining to the launch include:

  • Manufacturing: Access is currently working with its contract liquid manufacturer, Accupac, on initial clinical and stability batches, and expects to have initial commercial quantities available in 1Q 2010.
  • Reimbursement: Access is working with outside regulatory consultants in developing and finalizing its reimbursement strategy as it pertains to third-party payors and Medicare/Medicaid.
  • Clinical: Consistent with strategies employed by its global marketing partners, Access is working with key opinion leaders to develop a strategy for post-approval studies if and as needed. Access believes that its approved label indication and directions for use supports positioning MuGard as a preventative for oral mucositis caused by radiation and chemotherapy treatments, and provides for expansion into treatment of all types of oral wounds including aphthous ulcers, canker sores and traumatic ulcers, such as those caused by oral surgery.
  • Marketing/Sales: Access has signed a deal with iMedicor to support online eMarketing efforts and education of oncologists, radiation oncologist and support staff as it pertains to oral mucositis and MuGard specifically. Access intends to build a hybrid, dedicated salesforce with oncology supportive care experience.
  • Co-Promotion: Access continues to seek potential co-promotion arrangements with pharmaceutical and biotechnology companies in the oncology and oncology
    '/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Access MediQuip Moves Company Headquarters to Lake Mary, Florida
2. Japanese Cancer Patients Will Have Access to Compensator-Based IMRT with Opening of .decimal, Inc. Office in Tokyo and Hiring of Key Personnel
3. CMS Admits New Surety Bond and Accreditation Requirement for Home Medical Equipment Suppliers Creating Patient Access Issues
4. Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback
5. Ortho Clinical Diagnostics Receives FDA Approval for First Anti-HIV 1+2 Test for Use on Random Access, Integrated Laboratory Testing System
6. New Orggit iPhone Application Provides Mobile Access to Important Documents, Medical Information and Personal Data
7. Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM)
8. ShowerBuddy - Affordable, Accessible Bathing
9. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
10. Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story
11. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... , May 19, 2013  The non-surgical ... temperature radiofrequency (RF) energy is effective in control ... reduces the need for medication 10 years post-procedure, ... today at the Digestive Disease Week (DDW) meeting ... . "The sustained improvement ...
(Date:5/18/2013)... NEW YORK , May 18, 2013 /PRNewswire/ ... securities law firm, is investigating potential securities fraud ... (NASDAQ: AVEO). (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ... the Company and its executives violated federal securities ... regarding the Company,s Phase III drug trials for ...
(Date:5/17/2013)... , May 17, 2013  Lakeland Industries, Inc. (NASDAQ: ... protective clothing for industry, healthcare and to first responders ... its financial results for the fiscal 2013 fourth quarter ... 21, 2013 at stock market close and will conduct ... p.m. eastern. (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) ...
Breaking Medicine Technology:Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2
...  theVisualMD, www.thevisualmd.com , the world,s leading health visualization resource ... Visual Rules of Wellness. Quest Diagnostics (NYSE: DGX ... services, is the official sponsor of the initiative,s first rule ... of Wellness aim to bring readers a new understanding of ...
... 3, 2012   GP Strategies Corporation (NYSE: ... of sales and technical training, e-Learning solutions, management consulting ... L.P. ("Sagard Capital") has agreed to purchase 350,000 shares ... The closing of the transaction is subject to customary ...
Cached Medicine Technology:theVisualMD Launches a Revolutionary New Visual Path to Wellness 2theVisualMD Launches a Revolutionary New Visual Path to Wellness 3theVisualMD Launches a Revolutionary New Visual Path to Wellness 4Sagard Capital Increases Ownership in GP Strategies by 350,000 Shares in a Private Transaction with Bedford Oak Partners, L.P. 2Sagard Capital Increases Ownership in GP Strategies by 350,000 Shares in a Private Transaction with Bedford Oak Partners, L.P. 3
(Date:5/20/2013)... data mining solutions company for health and wellness, has ... of labeling claims for the composition of probiotic products ... Drug Administration (FDA) and CosmosID conducted side-by-side analysis of ... have been reported at the American Society for Microbiology. ... the identity of species and strains present in the ...
(Date:5/20/2013)... Dalton, Georgia (PRWEB) May 20, 2013 ... fields, has significantly expanded its presence in the Midwest ... office in Kansas City, Missouri. Sporturf Midwest is ... focus on Iowa, Nebraska, Missouri and Kansas. , ... Sporturf has not really been in before,” noted Shonk. ...
(Date:5/20/2013)... Online education provides the convenience, flexibility and cost-saving ... According to the American Heart Association, 27% of ... to eLearning due to changing economic conditions. The ... budgets, but it is also proven to enhance ... higher retention of content is probable, given the ...
(Date:5/20/2013)... a consequence of diabetic foot ulcer that does not ... situation are very limited. In his doctoral thesis Yue ... of Medical Biochemistry and Biophysics at Ume University presented ... completely change the lives of millions of patients. , ... wounds that largely impair the quality of life in ...
(Date:5/20/2013)... TX (PRWEB) May 20, 2013 ... portfolio of employee benefit, payroll products and services and ... that both are selected as finalists for the 2013 ... Fastest-Growing Company of the Year category, and CompuPay is ... Each finalist will ultimately be a Gold, Silver or ...
Breaking Medicine News(10 mins):Health News:CosmosID unveils new tool for faster, specific and accurate testing of probiotics products 2Health News:Sporturf Expands into the Midwestern U.S. 2Health News:Swank HealthCare Announces New Offering of Additional American Heart Association’s Accredited Online Courses 2Health News:Discovery of a novel medicine for the treatment of chronic wounds 2Health News:BenefitMall And CompuPay, Inc., A BenefitMall Company, Named As Finalists In 2013 American Business Awards 2Health News:BenefitMall And CompuPay, Inc., A BenefitMall Company, Named As Finalists In 2013 American Business Awards 3
... Feb. 1 issue of the journal SLEEP ... the levels of specific cytokines that are important in ... be the pathway linking extreme sleep durations to an ... self-reported sleep duration was associated with an eight-percent increase ...
... of Medicine have identified a protein critical for the ... protein slowed or prevented tumor growth in mice and ... low oxygen that occur in solid tumors. , "This ... tumor,s ability to grow," said cancer biologist Amato Giaccia, ...
... Higher temperatures when inside and more layers when outside are ... often focus their wintertime worries on fears of slipping on ... the risks of being too cold, advises the U.S. National ... exposure to the cold lessens as people age, putting the ...
... has little effect, but active practice plays a role, ... People who regularly attend religious services may be less ... suggests. , University of Manitoba researchers analyzed data from ... Community Health Survey to study the relationship between spirituality, ...
... Other Products Within the NutriSystem Food Portfolio Are Affected ... a leading provider of weight management products and services, ... Peanut Butter Granola Bar due to the expanded recall ... peanut products manufactured from January 1, 2007 to the ...
... recently presented at the annual meeting of the Society ... pregnant women did not reduce the risk of preterm ... that periodontal therapy during pregnancy can lessen the chance ... of Periodontology (AAP) has not yet received the opportunity ...
Cached Medicine News:Health News:Study suggests that inflammation may be the link between extreme sleep durations and poor health 2Health News:Stanford study prevents pancreatic tumor growth in mice by inhibiting key protein 2Health News:Stanford study prevents pancreatic tumor growth in mice by inhibiting key protein 3Health News:With Age Comes Greater Risk of Hypothermia 2Health News:NutriSystem Expands Voluntary United States Recall of Peanut Butter Granola Breakfast Bar to Include Canada Due to Possible Peanut Corporation of America (PCA) Contamination and Potential Health Risk 2Health News:NutriSystem Expands Voluntary United States Recall of Peanut Butter Granola Breakfast Bar to Include Canada Due to Possible Peanut Corporation of America (PCA) Contamination and Potential Health Risk 3
Anti Gliadin IgG Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum....
Anti Gliadin IgA Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum....
... the proper work area solution to manage ... and efficient way.,The progressive semi-automated Urisys 1800 ... data flow, supported by optional barcode reader ... accelerates analysis while high quality chemistries provide ...
... Estriol (E3) is one of the 3 ... estradiol and estrone). In terms of estrogenic ... estradiol [1]. Estriol is produced almost exclusively ... produced in the normal human fetus. During ...
Medicine Products: